Epithelial Ovarian Cancer – Adjuvant Measures with Potential for Slowing Its Spread and Boosting or Restoring its Chemosensitivity
Epithelial ovarian cancer accounts for more deaths than any other gynecological cancer. If surgery fails to achieve a cure, chemotherapy is usually effective initially, but most cancers eventually evolve to resistance and progress. This essay discusses a number of nutraceuticals, drugs, or other strategies that have potential for amplifying or restoring response to chemotherapy drugs, and/or for slowing cancer spread.